中国医药导刊 ›› 2019, Vol. 21 ›› Issue (12): 753-756.
• 病例报告 • 上一篇 下一篇
贾东丽1,井慧超2
收稿日期:
修回日期:
出版日期:
发布日期:
Received:
Revised:
Online:
Published:
摘要: 目的:分析1例化疗后Ⅳ度骨髓抑制患者的药学监护,加强药学监护,保障用药安全。方法:临床药师对1例Ⅳ度骨髓抑制患者从升白细胞、升血小板、预防感染及粒细胞缺乏伴发热患者退热药物选择等方面开展药学监护。结果:临床药师对患者进行了全程药学监护,对治疗方案提出了建议,发挥了临床药师的作用。结论:临床药师对患者实施药学监护,使临床用药更加合理、有效、安全。
Abstract: Objective:The pharmaceutical care for a patient with chemotherapy-induced Ⅳ degree myelosuppression was analyzed to strengthen pharmaceutical care, safeguard drug use. Methods: Clinical pharmacists performed the pharmaceutical care through leukocyte and platelet elevation,infection prevention and selection of antipyretic drugs for the patient with agranulocytosis and fever. Results: Clinical pharmacists gave full pharmaceutical care to the patient, and made suggestions on the treatment plan, played the role of clinical pharmacists. Conclusion: The pharmaceutical care performed by clinical pharmacist can enhance the reasonable, effectiveness and safety of medication.
中图分类号:
R979.1
R969.3
贾东丽 井慧超. 1例化疗致Ⅳ度骨髓抑制患者的药学监护[J]. 中国医药导刊, 2019, 21(12): 753-756.
0 / / 推荐
导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks
链接本文: http://www.zgyydk.cn/CN/
http://www.zgyydk.cn/CN/Y2019/V21/I12/753